Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9434928 Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides

Patent 9434928 was granted and assigned to Nationwide Children's Hospital on September, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
November 21, 2012
Date of Patent
September 6, 2016
Patent Application Number
14360243
Patent Citations Received
‌
US Patent 11975056 AADC polynucleotides for the treatment of Parkinson's disease
0
‌
US Patent 11913012 Cardiac cell reprogramming with myocardin and ASCL1
0
‌
US Patent 12121595 Methods and materials for GALGT2 gene therapy
0
‌
US Patent 12104165 Adeno-associated virus with engineered capsid
0
‌
US Patent 11759506 AADC polynucleotides for the treatment of Parkinson's disease
‌
US Patent 11781156 Plakophillin-2 gene therapy methods and compositions
‌
US Patent 11883506 Plakophilin-2 (PKP2) gene therapy using AAV vector
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9434928
Patent Primary Examiner
‌
Maria Leavitt

Find more entities like US Patent 9434928 Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo